Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Bajaj Healthcare surges after secures SEC recommendation for Cenobamate tablets
Bajaj Healthcare soared 12.98% to Rs 345 after the company said that Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO) has recommended for grant of approval for manufacturing and marketing of Cenobamate Tablets.
Omaxe Ltd leads gainers in 'B' group
Bajaj Healthcare Ltd, Prakash Pipes Ltd, Gujarat Natural Resources Ltd and Krishival Foods Ltd Partly Paidup are among the other gainers in the BSE's 'B' group today, 29 June 2026.
Stock Alert: Aurobindo Pharma, Likhitha Infra, Vikran Engineering, Ashoka Buildcon, Bajaj Healthcare
Aurobindo Pharma announced that the United States Food and Drug Administration (USFDA) had completed an inspection at its wholly owned subsidiary, Auroactive Pharma, located in Andhra Pradesh.
Stocks to Watch for June 29: HDFC Bank, Kotak Mahindra Bank, Dr Reddy’s and more
After an extended weekend, Dalal Street returns to a packed corporate news flow. From IRFC's successful OFS and Power Grid's fundraising plans to fresh developments at HDFC Bank, KEC International, Aurobindo Pharma and Bajaj Healthcare, here are the stocks likely to remain in focus on Monday.
Bajaj Healthcare secures SEC recommendation for Cenobamate tablets
Bajaj Healthcare announced that Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO) has recommended for grant of approval for manufacturing and marketing of Cenobamate Tablets.
Bajaj Healthcare becomes first in India to get SEC recommendation for Cenobamate tablets
On Thursday (June 25), shares of Bajaj Healthcare Ltd ended at ₹302.40, down by ₹9.05, or 2.91%, on the BSE.
At 100, the Bajaj Group is writing a new chapter—on healthcare
After 100 years of saying no to diversification, one of India’s fastest-growing wealth engines is finally scratching its ultimate itch. Powered by a ₹5,800-crore dividend chest, the billionaire cousins from the Bajaj Group have said ‘yes’ to one sector: healthcare.
Bajaj Group to enter healthcare biz with Rs 2k cr bet in Pune; expand to 7 cities in a decade
The Bajaj group is entering the healthcare sector. A significant investment of over Rs 2,000 crore is planned for Pune over the next three years. The group aims to establish a comprehensive healthcare model. This initiative will expand to multiple cities in the coming decade. The focus is on providing care from prevention to acute intervention.
Bajaj Healthcare reports dismal Q4 PAT
Bajaj Healthcare reported a standalone net loss of Rs 22.85 crore in Q4 FY26, compared with a net profit of Rs 11.17 crore posted in Q4 FY25.
Bajaj Healthcare reports standalone net loss of Rs 22.85 crore in the March 2026 quarter
Sales decline 0.91% to Rs 153.06 crore
Bajaj Healthcare reports Q4 net loss of ₹22.9 crore, recommends final dividend
Revenue slips marginally year-on-year, while EBITDA and margins improve sharply in the March quarter
Buy, Sell Or Hold: Kalyan Jewellers, Bajaj Auto, Eternal, Siemens Energy And Max Healthcare — Ask Profit
Experts shared buy, sell and hold recommendations on NDTV Profit's 'Ask Profit' show.